Clinical trial
Efficacy/Safety of Valsartan Plus Amlodipine and Amlodipine Alone in Patients…
NCT00413049 · Novartis, Industry · Completed
Key facts
| NCT number | NCT00413049 |
|---|---|
| Title | Efficacy/Safety of Valsartan Plus Amlodipine and Amlodipine Alone in Patients With Hypertension |
| Official title | A Multi-national, Multicenter, Double-blind, Double-dummy, Randomized, Active-controlled, Parallel Study Comparing the Efficacy and Safety of Valsartan/Amlodipine 80/5 mg to Amlodipine 5 mg Alone Once Daily in Patients With Mild to Moderate Essential Hypertension Not Adequately Controlled With… |
| Lead sponsor | Novartis, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Hypertension |
| Intervention type | Drug |
| Interventions | Valsartan/amlodipine 80/5 mg, Amlodipine 5 mg |
| Enrollment | 698 |
| Start date | Jan 1, 2007 |
| Primary completion | Nov 1, 2007 |
| Completion | Nov 1, 2007 |
| First posted | Dec 19, 2006 |
| Last update posted | Apr 29, 2011 |
| Countries | China |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: